Financhill
Back

Denali Therapeutics Quote, Financials, Valuation and Earnings

Buy
66

DNLI
Denali Therapeutics

Last Price:
20.52
Seasonality Move:
8.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Denali Therapeutics Price Quote

$20.52
+0.01 (+1.38%)
(Updated: May 18, 2024 at 5:41 AM ET)

Denali Therapeutics Key Stats

Buy
66
Denali Therapeutics (DNLI) is a Buy

Day range:
$19.95 - $20.78
52-week range:
$14.56 - $33.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.52
P/B ratio:
2.01%

Volume:
750.2K
Avg. volume:
1.1M
1-year change:
-31.04%
Market cap:
$2.9B
Revenue:
$330.5M
EPS:
$-0.96

How Much Does Denali Therapeutics Make?

Data Unavailable

Is Denali Therapeutics Growing As A Company?

Data Unavailable

Denali Therapeutics Stock Price Performance

What Is Denali Therapeutics 52-Week High & Low?

Denali Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Denali Therapeutics?

Is Denali Therapeutics Cash Flow Positive?

  • What Is DNLI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$412.8M
  • What Is Denali Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $516.5M
  • What Is Denali Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$111.2M

Denali Therapeutics Return On Invested Capital

Data Unavailable

Denali Therapeutics Earnings Date & Stock Price

Denali Therapeutics Competitors

  • Who Are Denali Therapeutics's Competitors?
    Below is a list of companies who compete with Denali Therapeutics or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Armata Pharmaceuticals Inc (ARMP)
    • Perspective Therapeutics Inc (CATX)
    • Halozyme Therapeutics Inc (HALO)
    • Protalix BioTherapeutics Inc (PLX)

Denali Therapeutics Dividend Yield

Data Unavailable

Denali Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -17.47%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 38.67
Upside from Last Price: 88.53%

Major Shareholders

  • How many DNLI shares are owned by institutional investors?
    176M DNLI shares are owned by institutional investors
  • How many DNLI shares are owned by insiders?
    2.8M DNLI shares are owned by insiders